[Why Coronary CTA will affect the diagnosis and management of stable coronary artery disease?]

Area of Science:

• Cardiology
• Diagnostic Imaging
• Medical Technology

Background:

• Traditionally, non-invasive functional tests were the standard for evaluating stable coronary artery disease (CAD).
• These tests have limitations, including inconclusive results or inability to perform due to patient factors.
• Coronary CTA (CCTA) has emerged as a significant advancement in CAD diagnosis.

Purpose of the Study:

• To evaluate the role of Coronary CTA (CCTA) in the diagnostic work-up of patients with stable coronary artery disease (CAD).
• To explore CCTA's potential to challenge and modify existing diagnostic algorithms for CAD.
• To highlight CCTA as a cornerstone in patient management due to limitations of traditional methods.

Main Methods:

• Review of current indications and emerging applications of CCTA in CAD diagnosis.
• Comparison of CCTA's efficacy against traditional non-invasive functional tests.
• Discussion of CCTA's integration into revised diagnostic pathways for suspected CAD.

Main Results:

• CCTA demonstrates high efficacy in excluding significant coronary artery disease.
• It is particularly valuable in patients with altered ECGs, inability to stress, or indeterminate functional test results.
• CCTA offers a minimally invasive anatomical assessment, complementing or replacing functional tests.

Conclusions:

• CCTA is poised to significantly alter the standard diagnostic work-up for patients with CAD.
• Its ability to provide anatomical detail addresses limitations of functional testing.
• The role of CCTA in CAD management is expected to expand, potentially becoming a primary diagnostic tool.